JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

Search

Smith & Nephew PLC ADR

Закрыт

35.07 3

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

34.05

Макс.

35.31

Ключевые показатели

By Trading Economics

Доход

296M

Продажи

3B

P/E

Средняя по отрасли

30.589

84.243

Дивидендная доходность

2.22

Рентабельность продаж

9.895

Сотрудники

17,000

EBITDA

723M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+0.82% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.22%

2.28%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

15B

Предыдущая цена открытия

32.07

Предыдущая цена закрытия

35.07

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Smith & Nephew PLC ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

5 февр. 2026 г., 00:00 UTC

Популярные акции

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

4 февр. 2026 г., 22:55 UTC

Отчет

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

4 февр. 2026 г., 21:44 UTC

Отчет

Arm Holdings 3Q Profit Falls Despite Revenue Growth

4 февр. 2026 г., 21:39 UTC

Отчет

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

5 февр. 2026 г., 00:00 UTC

Отчет

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

5 февр. 2026 г., 00:00 UTC

Отчет

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

4 февр. 2026 г., 23:46 UTC

Обсуждения рынка

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

4 февр. 2026 г., 23:45 UTC

Отчет

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

4 февр. 2026 г., 23:32 UTC

Обсуждения рынка

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

4 февр. 2026 г., 22:59 UTC

Приобретения, слияния, поглощения

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

4 февр. 2026 г., 22:30 UTC

Отчет

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

4 февр. 2026 г., 22:30 UTC

Отчет

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

4 февр. 2026 г., 22:21 UTC

Отчет

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 февр. 2026 г., 22:17 UTC

Обсуждения рынка

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

4 февр. 2026 г., 22:15 UTC

Обсуждения рынка

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

4 февр. 2026 г., 22:00 UTC

Обсуждения рынка

ESG Roundup: Market Talk

4 февр. 2026 г., 21:53 UTC

Отчет

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

4 февр. 2026 г., 21:51 UTC

Отчет

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 февр. 2026 г., 21:50 UTC

Обсуждения рынка

Tech, Media & Telecom Roundup: Market Talk

4 февр. 2026 г., 21:50 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Financial Services Roundup: Market Talk

4 февр. 2026 г., 21:50 UTC

Обсуждения рынка
Отчет

Auto & Transport Roundup: Market Talk

4 февр. 2026 г., 21:50 UTC

Обсуждения рынка

Health Care Roundup: Market Talk

4 февр. 2026 г., 21:45 UTC

Отчет

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

4 февр. 2026 г., 21:44 UTC

Отчет

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

4 февр. 2026 г., 21:43 UTC

Отчет

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

4 февр. 2026 г., 21:41 UTC

Отчет

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 февр. 2026 г., 21:36 UTC

Обсуждения рынка

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

4 февр. 2026 г., 21:30 UTC

Отчет

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 февр. 2026 г., 21:30 UTC

Отчет

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 февр. 2026 г., 21:30 UTC

Отчет

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC ADR Прогноз

Целевая цена

By TipRanks

0.82% рост

Прогноз на 12 месяцев

Средняя 34.46 USD  0.82%

Максимум 34.91 USD

Минимум 34 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

2 ratings

0

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

26.64 / 28.37Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat